Near Infrared Imaging Market Forecast 2022-2032 - Market Size, Drivers, Trends, And Competitors

The recently unveiled analysis report on the Near Infrared Imaging Market by Transparency Market Research paints a promising picture for the industry. With global sales reaching US$ 213.6 million in 2021, the projected growth from 2022 to 2032 at a CAGR of 12.7% signifies a thriving market set to reach US$ 3.6 billion by the end of the forecast period. Preclinical Imaging emerges as the leading revenue-generating application, with an anticipated CAGR of over 14.2% during 2022 - 2032.

Near Infrared Imaging plays a crucial role in the medical imaging landscape, with applications ranging from preclinical research to surgeries and disease diagnosis. The report indicates a historical growth rate of approximately 11.4% CAGR from 2017 to 2021, with the market poised for further expansion. The rise in neurological disorders and cancer cases worldwide, notably breast cancer, underscores the demand for advanced imaging methods, propelling the growth of the near-infrared medical imaging market.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=68369
Key Players and Market Developments
Some of the key players in the Near Infrared Imaging Market include Carl Zeiss Meditec AGLI-COR, Inc., Quest Medical Imaging B.V., Olympus, Shimadzu Corporation, Mizuho Medical Co, Ltd., Hamamatsu Photonics K.K., Stryker Corporation, Quest Innovations B.V., Karl Storz SE & Co. KG, and Teledyne Princeton Instruments.
Driving Factors:

Increased Prevalence of Diseases:

The escalating number of cancer, cardiovascular, gastrointestinal, and reconstructive surgeries drives the demand for near-infrared imaging.
Cosmetic surgery's significant growth, as reported by the American Society of Plastic Surgeons, is a notable factor influencing the market.
Technological Advancements:

Near Infrared technology finds applications in hospitals and clinics for detecting bedsores, avoiding surgical failures, and preventing accidental damage to blood vessels during surgeries.
Innovative developments like the Dolphin system from the Massachusetts Institute of Technology further contribute to market expansion.
Aging Population and Healthcare Costs:

The aging global population, as predicted by the World Health Organization, is anticipated to increase the utilization of near-infrared imaging in healthcare.
Rising healthcare costs, notably in the United States, are driving the adaptation of near-infrared imaging technologies.
Market Restraints:

FDA Approval Challenges:

Limited FDA approval for fluorophores hampers the deployment of targeted imaging agents.
The lengthy and expensive approval process acts as a constraint to the market growth.
Specificity and Imaging Agent Limitations:

The lack of specificity for tumors or healthy tissues in approved imaging agents limits their efficiency.
Molecularly customized NIRF imaging agents face constraints in clinical settings, reducing their widespread application.
𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 | 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 - https://www.transparencymarketresearch.com/checkout.php?rep_id=68369<ype=S
Regional Insights:

Asia Pacific:

The Asia Pacific market is poised to offer significant opportunities, with a projected valuation of over US$ 256 million by 2032.
The region's increasing burden of chronic diseases, such as cancer and cardiovascular ailments, contributes to the growth of near-infrared imaging applications.
United States:

The U.S. is anticipated to lead the market, reaching US$ 235 million by 2032, driven by rising healthcare costs and a high incidence of reported cancer cases.
Country-wise Analysis:

U.K.:

The near-infrared imaging market in the U.K. is forecasted to reach US$ 32.1 million by 2032, with a CAGR of 13.4%.
Japan:

Japan's market is expected to grow at a CAGR of 16.5%, reaching US$ 38 million by 2032.
South Korea:

The South Korean market is projected to gross US$ 23.7 million by 2032, growing at a CAGR of 16.1%.
Category-wise Insights:

Preclinical Imaging Dominates:

The preclinical imaging segment is anticipated to be the most lucrative, growing at a CAGR of over 14.2% during 2022-32.
Near-infrared imaging's role in preclinical research for various diseases, including cancer and inflammation, propels its market growth.
The Near Infrared Imaging Market is on a trajectory of impressive growth, driven by technological advancements, increasing prevalence of diseases, and a growing aging population. While challenges like FDA approval hurdles exist, the market's potential is undeniable. With applications spanning preclinical research to surgeries, near-infrared imaging continues to illuminate the path toward more effective and advanced healthcare diagnostics and interventions.

About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.